SCHEMBL4504366

SCHEMBL4504366

N#Cc1ccc(-c2ccc3c(NC(=O)c4cc(F)c(F)c(F)c4F)n[nH]c3c2)cc1

nearest known ligand 0.59

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 8/20 0.59
HDAC6 Q9UBN7 9/20 0.48
FGFR1 P11362 1/20 0.48
FGFR2 P21802 1/20 0.48
FGFR3 P22607 1/20 0.48
CYP1A2 P05177 1/20 0.44
GSK3A P49840 3/20 0.44
PIK3CD O00329 1/20 0.44
PIM1 P11309 1/20 0.44
CDK2 P24941 1/20 0.44
AAK1 Q2M2I8 1/20 0.44
FGFR4 P22455 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4494371 0.91 GSK3B (0.49) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4496084 0.88 GSK3B (0.60) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4500881 0.87 HDAC6 (0.62) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4484392 0.87 GSK3B (0.60) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4494493 0.86 GSK3B (0.57) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4503174 0.86 HDAC6 (0.55) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4486229 0.86 GSK3B (0.59) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4486307 0.84 GSK3B (0.60) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4488725 0.84 GSK3B (0.60) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4491906 0.84 GSK3B (0.61) GSK3BHDAC6FGFR1FGFR2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed